hiv
infect
individu
shown
predispos
pulmonari
infect
even
receiv
antiretrovir
therapi
alveolar
macrophag
am
play
critic
role
lung
innat
immun
contradictori
result
report
regard
function
follow
hiv
infect
use
siv
rhesu
macaqu
model
document
effect
siv
infect
phenotyp
function
properti
am
follow
infect
siv
am
bronchoalveolar
lavag
bal
sampl
postinfect
wpi
compar
bal
sampl
macaqu
express
proinflammatori
cytokin
chemokin
rant
drastic
increas
compar
am
macaqu
p
drop
significantli
progress
chronic
infect
phagocyt
activ
am
elev
compar
am
naiv
anim
p
p
respect
significantli
decreas
p
p
respect
abil
am
chronic
infect
anim
perform
sivspecif
antibodydepend
phagocytosi
adp
also
diminish
p
acut
siv
infect
associ
increas
express
subsequ
declin
diseas
progress
frequenc
am
show
strong
trend
toward
correl
sivspecif
adp
express
neg
correl
viral
load
r
p
suggest
contribut
viremia
control
importantli
found
express
am
show
strong
trend
toward
correl
plasma
viral
load
r
p
indic
similar
overexpress
tcell
express
am
may
also
associ
diseas
progress
am
predominantli
express
remain
consist
cours
infect
blockad
enhanc
sivspecif
adp
am
chronic
infect
indic
pathway
may
modul
function
activ
am
stage
find
provid
new
insight
dynam
siv
infect
lead
dysfunct
alter
pulmonari
innat
immun
result
suggest
new
pathway
exploit
develop
therapi
target
pulmonari
diseas
suscept
hivinfect
individu
hiv
infect
individu
shown
predispos
pulmonari
infect
even
receiv
antiretrovir
therapi
alveolar
macrophag
am
play
critic
role
lung
innat
immun
contradictori
result
report
regard
function
follow
hiv
infect
use
siv
rhesu
macaqu
model
document
effect
siv
infect
phenotyp
function
properti
am
follow
infect
siv
am
bronchoalveolar
lavag
bal
sampl
postinfect
wpi
compar
bal
sampl
macaqu
express
proinflammatori
cytokin
chemokin
rant
drastic
increas
compar
am
macaqu
p
drop
significantli
progress
chronic
infect
phagocyt
activ
am
elev
compar
am
naiv
anim
p
p
respect
significantli
decreas
p
p
respect
abil
am
chronic
infect
anim
perform
sivspecif
antibodydepend
phagocytosi
adp
also
diminish
p
acut
siv
infect
associ
increas
express
subsequ
declin
diseas
progress
frequenc
am
show
strong
trend
toward
correl
sivspecif
adp
express
neg
correl
viral
load
r
p
suggest
contribut
viremia
control
importantli
found
express
am
show
strong
trend
toward
correl
plasma
viral
load
r
p
indic
similar
overexpress
tcell
express
am
may
also
associ
diseas
progress
am
predominantli
express
remain
consist
cours
infect
blockad
enhanc
sivspecif
adp
am
chronic
infect
indic
pathway
may
modul
function
activ
am
stage
find
provid
new
insight
dynam
siv
infect
lead
dysfunct
alter
pulmonari
innat
immun
result
suggest
new
pathway
exploit
develop
therapi
target
pulmonari
diseas
suscept
hivinfect
individu
keyword
alveolar
macrophag
siv
rhesu
macaqu
antibodydepend
phagocytosi
bronchoalveolar
lavag
introduct
macrophag
found
tissu
infect
individu
play
continu
role
pathogenesi
although
earlier
studi
report
macrophag
major
cell
type
initi
infect
hiv
recent
studi
shown
cell
preferenti
target
hivsiv
site
transmiss
howev
macrophag
still
serv
target
viru
vivo
sustain
viral
replic
dissemin
viru
serv
viral
reservoir
postinfect
cell
macrophagemonocyt
lineag
vari
greatli
phenotyp
longev
phagocyt
immunoregulatori
secretori
properti
macrophag
categor
classic
altern
activ
base
surfac
marker
function
role
macrophag
mediat
inflammatori
respons
pathogen
macrophag
antiinflammatori
properti
promot
tissu
repair
remodel
alveolar
macrophag
lung
uniqu
express
phenotyp
marker
indic
abil
quickli
respond
pathogen
also
prevent
immun
activ
respons
harmless
antigen
enter
alveolar
lumen
express
chemokin
receptor
make
vulner
hiv
infect
howev
macrophag
may
poorli
suscept
hiv
induc
cytopath
effect
minim
consequ
hiv
infect
macrophag
transcriptom
observ
contrast
express
hiv
nef
envelop
induc
macrophag
activ
indirect
activ
also
occur
exposur
uninfect
macrophag
viral
gene
product
cytokin
infect
cell
import
lung
phagocyt
yet
obtain
hivinfect
individu
shown
contradictori
result
regard
impact
viral
infect
phagocytosi
studi
shown
impair
phagocytosi
opportunist
pathogen
other
report
chang
phagocyt
activ
infect
variat
outcom
may
result
differ
length
infect
relianc
use
monocyt
deriv
macrophag
mdm
infect
cell
line
may
ideal
repres
clinic
situat
macrophag
util
receptor
intern
antibodyopson
virion
infect
cell
potenti
lead
antibodymedi
clearanc
infecti
materi
antibodydepend
phagocytosi
adp
contribut
protect
viral
infect
influenza
west
nile
adenoviru
sar
coronaviru
howev
adpmedi
protect
macrophag
hiv
infect
observ
investig
dynam
sivrel
chang
activ
function
sampl
bronchoalveolar
lavag
bal
siv
infect
rhesu
macaqu
acut
chronic
infect
respons
siv
infect
consist
phenotyp
chang
alter
proinflammatori
respons
abil
respond
antigen
phagocyt
activ
express
link
sivspecif
adp
viral
control
acut
infect
novel
result
show
increas
express
program
chronic
infect
macaqu
posit
correl
express
am
siv
viremia
believ
first
report
express
am
siv
infect
macaqu
result
suggest
associ
express
macrophag
dysfunct
lack
viremia
control
fortynin
femal
indian
rhesu
macaqu
use
studi
hous
nci
anim
facil
bethesda
md
protocol
nci
facil
accredit
associ
assess
accredit
laboratori
anim
care
intern
anim
care
use
committe
approv
anim
experi
prior
studi
initi
standard
practic
follow
recommend
made
guid
care
use
laboratori
anim
unit
state
nation
institut
health
weatheral
report
thirti
macaqu
use
control
macaqu
challeng
weekli
intravagin
use
repeat
lowdos
siv
tcid
infect
confirm
macaqu
plasma
viral
load
siv
rna
copiesml
assess
droplet
digit
pcr
chung
et
al
manuscript
prepar
remain
five
macaqu
infect
intrarect
singl
high
dose
siv
tcid
infect
macaqu
euthan
wpi
remain
infect
macaqu
monitor
longitudin
wpi
bal
sampl
obtain
use
standard
techniqu
briefli
rhesu
macaqu
anesthet
endotrach
tube
insert
steril
salin
solut
mlkg
instil
suction
appli
recov
instil
fluid
lung
lavag
collect
steril
conic
tube
cell
pellet
centrifug
rpm
min
c
wash
ml
cold
pb
centrifug
repeat
cell
resuspend
count
cell
show
viabil
determin
trypan
blue
stain
bal
cell
enrich
am
deplet
epcam
cell
follow
reagent
use
rabbit
polyclon
antiepcam
genetex
irvin
ca
microbead
nonhuman
primat
miltenyi
biotec
auburn
ca
deplet
perform
use
mac
cell
separ
technolog
accord
manufactur
instruct
miltenyi
biotec
auburn
ca
enrich
am
stimul
h
media
rpmi
fb
penstrep
antianti
contain
purifi
nativ
envelop
advanc
bioscienc
laboratori
inc
rockvil
md
concentr
nm
lp
thermofish
scientif
waltham
ngml
concentr
experi
assess
cytokin
product
am
cell
stimul
lp
presenc
golgistop
bd
bioscienc
h
prior
intracellular
stain
adp
activ
measur
previous
describ
siv
biotinyl
biotinxx
microscal
protein
label
kit
life
technolog
grand
island
ny
incub
dilut
avidin
coat
sky
blue
fluoresc
bead
diamet
spherotech
lake
forest
il
overnight
c
enrich
am
plate
ubottom
well
plate
cellswel
undilut
balf
ad
determin
phagocyt
activ
independ
siv
specif
antibodi
balf
macaqu
use
sivspecif
adp
autolog
balf
infect
macaqu
use
mixtur
brought
final
dilut
media
ad
cell
incub
h
c
block
experi
bal
sampl
collect
macaqu
wpi
enrich
am
describ
incub
either
ultraleaf
purifi
antihuman
antibodi
biolegend
isotyp
control
sigmaaldrich
cell
incub
balf
use
normal
case
h
incub
paraformaldehyd
ad
fixat
fluoresc
bead
uptak
assess
use
bd
bioscienc
lsrii
flow
cytomet
bead
uptak
specif
made
possibl
focus
cell
autofluoresc
fitc
channel
phagocyt
score
sampl
calcul
multipli
frequenc
beadposit
cell
degre
phagocytosi
measur
mean
fluoresc
intens
mfi
divid
valu
normal
background
valu
cell
bead
either
pb
balf
divid
phagocyt
score
test
sampl
phagocyt
score
background
sampl
mous
antinonhuman
primat
antihuman
fluorochromeconjug
monoclon
ab
except
specifi
otherwis
known
crossreact
rhesu
macaqu
antigen
use
studi
follow
antibodi
use
surfac
stain
cell
wash
bd
permwash
incub
intracellular
stain
antibodi
min
rt
final
cell
wash
pb
stain
data
acquir
use
laser
bd
facsymphoni
bd
bioscienc
san
jose
ca
fluoresc
minu
one
fmo
isotyp
control
use
confirm
phenotyp
cytokin
express
popul
am
figur
data
analys
perform
flowjo
version
treestar
inc
ashland
softwar
antibodi
balf
measur
follow
well
greiner
highbind
area
plate
coat
overnight
c
ngwell
siv
determin
igg
ngwell
antirhesu
igg
alpha
diagnost
determin
total
igg
sodium
bicarbon
buffer
ph
sigmaaldrich
st
loui
mo
well
block
bsa
diluentblock
solut
kpl
distil
water
h
rt
balf
ad
incub
h
c
envspecif
igg
deriv
purifi
serum
igg
obtain
siv
infect
macaqu
quantifi
previous
describ
use
gener
standard
curv
envspecif
igg
purifi
rhesu
igg
nonhuman
primat
reagent
resourc
use
gener
standard
curv
total
igg
plate
wash
time
wash
solut
kpl
horseradish
peroxidaselabel
goat
antimonkey
igg
dilut
alpha
diagnost
ad
plate
incub
h
c
wash
describ
tetramethylbenzidin
tmb
peroxidas
substrat
kpl
ad
min
rt
color
develop
stop
phosphor
acid
sigma
plate
read
nm
use
biotek
plate
reader
siv
antibodi
level
express
ng
total
igg
statist
analysi
perform
use
oneway
anova
anova
tukey
multipl
comparison
test
indic
figur
legend
wilcoxon
matchedpair
sign
rank
test
also
use
indic
correl
analys
perform
nonparametr
spearman
correl
statist
gener
use
graphpad
prism
rhesu
macaqu
infect
siv
bal
collect
nineteen
macaqu
sampl
subsequ
time
point
bal
sampl
also
obtain
macaqu
am
bal
character
flow
cytometri
hladr
hi
int
figur
mean
frequenc
am
leukocyt
found
lavag
sampl
consist
report
bal
specimen
naiv
rhesu
macaqu
signific
chang
frequenc
am
observ
week
infect
figur
express
shown
identifi
phenotyp
chang
express
occur
fibrot
stage
lung
diseas
signific
chang
express
time
period
studi
observ
figur
also
observ
chang
percentag
am
express
costimulatori
molecul
indic
inflammatori
respons
record
may
associ
expans
cell
subset
figur
f
macrophag
secret
proinflammatori
cytokin
chemokin
respons
hiv
infect
howev
clear
dynam
cytokin
chemokin
respons
macrophag
cours
hivsiv
infect
shown
character
cytokin
level
collect
siv
infect
rhesu
macaqu
compar
level
am
macaqu
strong
proinflammatori
respons
seen
acut
phase
infect
express
am
significantli
increas
p
figur
express
level
significantli
lower
cytokin
express
remain
low
time
point
except
express
increas
significantli
compar
figur
express
level
significantli
higher
level
seen
popul
similarli
higher
level
chemokin
rant
found
am
macaqu
figur
express
decreas
level
compar
sampl
remain
low
time
point
figur
express
chang
cours
infect
figur
overal
observ
transient
increas
proinflammatori
cytokin
respons
decreas
level
compar
macaqu
chronic
phase
infect
assess
whether
am
lean
toward
antiinflammatori
role
chronic
infect
evalu
intracellular
express
am
figur
am
play
import
role
maintain
antiinflammatori
environ
lung
inde
express
am
detect
anim
frequenc
cell
significantli
higher
compar
acut
infect
anim
figur
interestingli
percentag
express
am
decreas
significantli
infect
progress
chronic
stage
figur
thu
siv
infect
associ
signific
spike
proinflammatori
respons
wane
chronic
infect
addit
low
proinflammatori
cytokin
respons
chronic
infect
associ
increas
am
investig
activ
bal
cell
obtain
acut
chronic
infect
macaqu
week
wpi
incub
nativ
tropic
siv
lp
h
intracellular
express
assess
figur
b
lp
induc
compar
level
am
naiv
acutelyinfect
anim
figur
b
howev
chronic
infect
macaqu
induc
intracellular
express
am
figur
b
lp
stimul
express
either
factor
level
induc
anim
suggest
dysfunct
state
am
figur
assess
whether
am
contribut
clearanc
siv
evalu
phagocyt
activ
abil
perform
adp
cours
siv
infect
use
bal
sampl
anim
sivinfect
macaqu
sampl
bal
sampl
contain
high
percentag
am
figur
cell
enrich
am
use
mac
deplet
epcam
posit
cell
figur
assess
phagocyt
capac
independ
siv
antibodi
enrich
cell
incub
siv
fluoresc
bead
balf
macaqu
prior
quantif
bead
uptak
signific
increas
phagocyt
activ
detect
acut
phase
figur
phagocytosi
decreas
compar
cell
activ
decreas
significantli
time
point
compar
acut
time
point
figur
prior
evalu
adp
am
assess
siv
igg
balf
figur
specif
igg
detect
level
maintain
continu
rise
determin
sivspecif
adp
am
macaqu
sampl
cours
siv
infect
incub
antigenco
bead
along
autolog
balf
phagocytosi
score
normal
score
obtain
use
balf
highlight
phagocyt
activ
associ
presenc
sivspecif
antibodi
figur
significantli
higher
phagocyt
score
detect
compar
time
point
indic
am
could
perform
sivspecif
adp
figur
assess
adp
am
chronic
infect
phagocyt
score
chronic
time
point
figur
normal
sivspecif
antibodi
level
figur
result
show
presenc
compar
antibodi
level
am
mediat
adp
activ
howev
activ
significantli
compromis
week
pi
figur
thu
capabl
adp
limit
time
period
chronic
infect
diminish
function
capac
am
chronic
stage
highlight
dysfunct
observ
upon
lp
stimul
figur
three
class
constitut
express
am
activ
role
protect
pathogen
airway
highaffin
lowaffin
occur
two
isoform
express
mainli
nk
cell
macrophag
express
neutrophil
infect
mdm
shown
compromis
express
signal
chain
possibl
lead
alter
phagocyt
activ
monocyt
chronic
infect
individu
also
shown
reduc
express
diminish
phagocyt
activ
howev
thu
far
correl
found
adp
hivsiv
viral
load
count
express
given
uniqu
featur
am
compar
tissu
macrophag
monocyt
import
phagocyt
function
lung
investig
whether
alter
express
am
cours
siv
infect
associ
adp
bal
naiv
macaqu
contain
am
figur
c
frequenc
mfi
remain
high
unchang
cours
infect
figur
c
e
f
contrast
mean
frequenc
cell
macaqu
signific
increas
frequenc
level
significantli
decreas
figur
low
frequenc
am
maintain
similar
increas
mfi
observ
acut
phase
infect
compar
anim
figur
howev
express
level
significantli
reduc
time
point
compar
level
figur
concert
decreas
frequenc
observ
sivspecif
adp
observ
figur
exhibit
strong
trend
toward
posit
correl
percentag
am
time
point
figur
mfi
figur
neg
correl
significantli
acut
plasma
viral
load
figur
data
suggest
play
import
role
sivspecif
adp
express
associ
earli
viral
load
control
character
dysfunct
observ
am
chronic
infect
macaqu
look
parallel
cell
exhaust
sinc
initi
descript
cell
exhaust
chronic
viral
infect
common
phenotyp
function
properti
attribut
dysfunct
state
regardless
type
pathogen
high
prolong
express
inhibitori
receptor
key
featur
cell
exhaust
chronic
viral
infect
particular
overexpress
receptor
tcell
play
major
role
cell
dysfunct
associ
hiv
infect
identifi
am
rhesu
macaqu
bal
assess
chang
express
am
macaqu
cours
siv
infect
figur
frequenc
am
assess
naiv
macaqu
compar
frequenc
siv
infect
anim
five
six
siv
macaqu
show
increas
frequenc
figur
frequenc
significantli
differ
time
point
p
p
respect
am
also
display
signific
increas
mfi
signifi
increas
express
receptor
figur
furthermor
percentag
am
correl
posit
viral
load
figur
also
observ
strong
trend
toward
correl
mfi
viral
load
figur
indic
associ
express
am
siv
diseas
progress
two
wellknown
ligand
via
inhibitori
effect
report
occur
program
death
ligand
program
death
ligand
shown
express
broadli
hematopoeit
nonhematopoeit
cell
restrict
express
pattern
document
name
antigen
present
cell
apc
order
identifi
potenti
role
pathway
function
look
express
ligand
am
siv
infect
am
macaqu
predominantli
express
high
level
figur
express
decreas
modestli
significantli
siv
infect
remain
consist
thereaft
hand
observ
minim
express
fold
lower
am
macaqu
figur
express
significantli
decreas
cours
siv
infect
result
indic
dysfunct
like
associ
increas
express
rather
chang
express
ligand
may
occur
pathway
identifi
whether
blockad
rescu
phagocytosi
examin
phagocyt
activ
am
chronic
infect
macaqu
presenc
block
antibodi
mous
igg
control
interestingli
found
higher
phagocyt
score
blockad
group
anim
p
indic
express
like
mechanist
link
impair
phagocyt
activ
figur
assess
cytokin
express
express
am
stimul
am
chronic
infect
macaqu
lp
compar
cytokin
express
popul
although
signific
found
lower
express
express
cell
compar
popul
figur
comparison
addit
cytokin
chemokin
rant
report
express
cytokin
could
detect
am
infect
macaqu
test
taken
togeth
data
strongli
suggest
express
am
siv
infect
may
marker
dysfunct
result
show
siv
macaqu
model
proinflammatori
respons
am
siv
infect
peak
acut
phase
infect
diminish
chronic
phase
observ
follow
stimul
lp
report
am
siv
infect
macaqu
perform
adp
earli
infect
activ
diminish
chronic
phase
novel
find
report
elev
percentag
am
chronic
infect
macaqu
posit
correl
viral
load
period
diminish
inflammatori
respons
adp
observ
percentag
am
stay
consist
cours
siv
infect
figur
viral
infect
lead
activ
macrophag
subsequ
releas
factor
recruit
addit
cell
innat
adapt
immun
system
lack
detect
macrophag
recruit
lung
may
result
concurr
lymphocyt
recruit
make
rel
number
macrophag
appear
consist
inde
higher
percentag
lymphocyt
bal
hivinfect
patient
report
estim
actual
number
multipli
cell
count
percentag
am
result
signific
differ
figur
includ
absolut
count
bead
part
initi
analysi
might
provid
definit
answer
variat
surfac
marker
express
am
week
siv
infect
also
seen
except
chang
express
figur
phenotyp
comparison
am
bal
hivinfect
uninfect
individu
also
shown
differ
proinflammatori
cytokin
chemokin
rant
induc
am
acut
infect
figur
rapid
secret
cytokin
chemokin
expect
innat
immun
system
initi
lymphocyt
recruit
establish
adapt
immun
prior
viral
spread
although
hivsiv
infect
rate
am
may
low
macrophag
respond
exposur
viral
particl
virusderiv
gene
product
nef
tat
envelop
follow
acut
phase
elev
cytokin
chemokin
respons
am
sustain
despit
exposur
viral
product
like
lp
gut
stimul
lp
nativ
ex
vivo
show
impair
respons
am
chronic
infect
macaqu
figur
indic
potenti
compromis
inflammatori
respons
lung
pathogen
novel
observ
consist
data
show
inhibit
releas
macrophag
respons
tolllik
receptor
tlr
stimul
hiv
infect
even
though
express
level
remain
unchang
desensit
tlr
ligand
am
result
viral
respiratori
infect
also
report
rant
bind
coreceptor
indic
potenti
protect
effect
entri
virus
pattern
chemokin
express
show
protect
effect
express
am
like
limit
acut
phase
infect
figur
lower
cytokin
chemokin
respons
acut
phase
infect
associ
increas
express
figur
fact
am
macaqu
express
highest
level
intracellular
figur
studi
shown
induct
secret
mrna
macrophagetrop
infect
mdm
compar
uninfect
cell
other
shown
increas
secret
mrna
level
vitro
hivinfect
pbmc
monocyt
mdm
review
differ
viru
tropism
target
cell
could
account
variat
observ
increas
level
detect
balf
hiv
infect
patient
howev
bal
sampl
could
origin
lymphocyt
upregul
hiv
infect
sum
data
indic
siv
diseas
progress
associ
increas
express
suggest
am
switch
regulatori
phenotyp
am
essenti
lung
microbi
clearanc
despit
report
function
affect
infect
recent
studi
shown
phagocyt
activ
impair
viral
load
activ
statu
macrophag
vari
cours
infect
track
phagocyt
activ
am
follow
siv
infect
provid
new
insight
dynam
function
am
readili
intern
antigen
coat
bead
acut
infect
abil
markedli
decreas
chronic
infect
anim
figur
initi
phagocyt
activ
nonspecif
antibodi
present
like
due
rise
proinflammatori
respons
acut
infect
figur
adp
observ
chronic
stage
infect
antibodi
level
increas
balf
figur
howev
continu
rise
antibodi
level
associ
increas
adp
fact
decreas
adp
activ
seen
later
chronic
infect
therefor
even
though
pattern
chemokin
express
am
cours
siv
infect
figur
suggest
frequenc
return
naiv
level
chronic
phase
infect
diminish
function
activ
observ
suggest
dysfunct
express
elev
acut
siv
infect
decreas
infect
progress
figur
data
partli
contrast
data
hivinfect
mdm
show
either
elev
chang
express
review
isoform
express
macrophag
consist
ligand
associ
disulfidelink
signal
subunit
shown
downregul
consequ
hiv
infect
result
aberr
downstream
signal
requir
phagocytosi
antibodi
use
recogn
ligand
bind
thu
loss
express
explain
downregul
alon
data
suggest
spite
initi
increas
frequenc
am
acut
infect
figur
prolong
hiv
infect
may
lead
diminish
express
outcom
may
observ
previous
vitro
mdm
infect
experi
mainli
mimic
acut
stage
infect
nevertheless
although
frequenc
am
dwindl
level
observ
anim
correl
trend
frequenc
am
adp
observ
figur
indic
import
receptor
adp
activ
mediat
am
furthermor
mfi
neg
correl
acut
viremia
suggest
import
role
phagocytosi
initi
viral
load
control
figur
pathway
play
key
role
neg
regul
adapt
immun
hiv
viral
infect
review
studi
explor
role
innat
immun
particularli
macrophag
express
cell
follow
immun
activ
role
tcell
exhaust
highli
express
chronic
viral
infect
describ
regard
macrophag
express
link
diminish
abil
clear
microbi
invas
septic
mice
inhibit
phagocyt
activ
tumor
immun
inabl
perform
phagocytosi
intracellular
kill
patient
tuberculosi
unlik
cell
express
macrophag
studi
describ
singl
posit
popul
also
identifi
singl
popul
am
deriv
chronic
infect
macaqu
figur
macaqu
clear
lung
infect
time
bal
collect
suggest
express
associ
siv
infect
direct
evid
implic
dysfunct
data
show
direct
correl
siv
viremia
suggest
keep
correl
describ
cell
diseas
progress
also
associ
express
am
figur
ligand
found
express
am
macaqu
express
level
low
subsequ
declin
siv
infect
figur
result
unexpect
contrast
studi
mdm
show
upregul
exposur
inactiv
hiv
virion
howev
alveolar
environ
inde
uniqu
unsurpris
respons
siv
infect
differ
vitro
exposur
mdm
virion
rodriguezgarcia
et
al
indic
differenti
regul
wherebi
presenc
increas
express
blockad
increas
express
analysi
express
am
studi
show
gradual
decreas
siv
infect
may
one
explan
observ
decreas
express
figur
express
howev
remain
high
increas
decreas
express
futur
analysi
factor
found
balf
could
provid
insight
dynam
pdl
express
am
blockad
experi
shown
enhanc
sivhivspecif
respons
prolif
abil
cytokin
product
exhaust
high
cell
keep
blockad
pathway
report
amelior
phagocyt
function
macrophag
found
tumor
microenviron
activ
tuberculosi
also
found
blockad
could
significantli
improv
phagocyt
activ
highlight
factor
play
role
dysfunct
am
figur
addit
although
signific
potenti
due
small
sampl
size
found
lower
abund
express
am
compar
popul
chronic
infect
figur
data
suggest
presenc
am
like
factor
inhibitori
role
exert
am
pathway
summari
longitudin
investig
provid
import
new
inform
consequ
siv
infect
am
novel
find
propos
role
wellrecogn
inhibitor
adapt
immun
respons
innat
immun
siv
infect
dataset
gener
studi
includ
manuscript
andor
supplementari
file
fortynin
femal
indian
rhesu
macaqu
use
studi
hous
nci
anim
facil
bethesda
md
protocol
nci
facil
accredit
associ
assess
accredit
laboratori
anim
care
intern
anim
care
use
committe
approv
anim
experi
prior
studi
initi
standard
practic
follow
recommend
made
guid
care
use
laboratori
anim
unit
state
nation
institut
health
weatheral
report
